State Ledger
Company profile

Celularity Inc CIK 1752828

Ticker
CELU (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Florham Park, NJ 07932
Fiscal year end
2025 (FY)
Market Data
Close
$1.49
Change
-$0.07
Change %
-4.19%
Volume
727

CELU · trading date Oct 12, 2026 · previous close $1.55 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$26.55M
Net income
-$91.72M
Total assets
$107.33M
Total liabilities
$145.39M
Stockholders' equity
-$38.06M
Cash & equivalents
$6.18M
Operating income
-$61.31M
Operating cash flow
-$13.25M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-04-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-230.9%
Net margin
-345.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
135.5%
Equity / assets
-35.5%
CapEx / revenue
—
Operating cash flow / net income
0.14×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $26.55M -$91.72M $107.33M $145.39M -$38.06M
2024 $54.22M -$57.89M $132.68M $123.85M $8.84M
2023 $22.77M -$196.30M $143.89M $102.93M $40.96M
2022 $17.98M $14.19M $401.07M $202.17M $198.90M
2021 $21.34M -$100.12M $414.13M $314.71M $99.42M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-14
Financials filed via
Form 10-K
filed 2026-04-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Florham Park, NJ 07932
170 PARK AVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies